Background Image
Table of Contents Table of Contents
Previous Page  42 / 132 Next Page
Show Menu
Previous Page 42 / 132 Next Page
Page Background

Food and Drug Administration


(2) In 2014, a total of 17,896 cases of drug abuse were reported by medical institutions. Results of

analysis are provided below:

a. The top-3 types of illegal drugs abused were heroin with 11,185 individual cases reported (62.5%),

(meth) amphetamine with 4,858 cases (27.1%), and ketamine with 1,626 cases (9.1%).

b. Drug types and demographics analysis found that ketamine was the most common drug abused

by those below 19 years of age. (Meth) amphetamine was the most common drug abused by

those from 20 to 29 years of age, while heroin was the most common drug abused by those 30

years of age or above.

c. The top reasons for drug abuse were


(36.6%) followed by

stress relief


2. The Results of National Drug Abuse Survey in 2014

a. To understand the current status and long-term trends of drug abuse in Taiwan, TFDA conducted


National Drug Abuse Survey

in 2014. The main objectives of the survey was to achieve in-

depth discussions on the behaviors, cause, frequency, source of substances, and substance use

issues amongst drug abusers to assess the effectiveness of policies and provide a reference for

formulating future directives.

b. Survey results indicated that lifetime prevalence for illegal drug use was 1.29% between the ages of

12 to 64 years. The top-3 types of illegal drugs used were amphetamine, ketamine, and cannabis.

The age group between 18 to 44 years of age was most likely to commit drug abuse. The most

commonly abused drug for those between 18 to 24 years of age was ketamine, while that for

those between 35 to 44 years of age was amphetamine. The leading motivation for first-time drug

abuse was


(66.7%) followed by

relaxation / stress relief


friends already using


(13.0%), and

for recreation


3. Establishment of Technology and Database for Drug Abuse

In response to the deteriorating drug abuse and addiction issues, TFDA continues to dedicate the

developing new technology and establishing databases to achieve the prevention effectively and

control of drug abuse. Important outcomes of 2014 are listed in Table 4-3.



Completed the synthesis of 13 standards and the establishment of

standard spectrum database of





To meet the test demands, the Standards

are extremely expensive or not commercially

available in Taiwan

Optimized spectrum conditions for 203 standards (including amphetamine,

cathinone, tryptamines, opioids, marjuana, synthetic cannabinoids,

cocaine, benzodiazepine and its metabolic derivatives) as well as

established secondary fragment mass spectrum database

To quickly screen the known or unknown

abuse drugs to prevent drug abuse

Developed the pre-treatment and GC-MS instrument methods for nine

items of synthetic cannabinoids such as JWH-018, JWH-122, JWH-250

and its metabolites in the urine

To accelerate drug abuse analysis time to

track trends in drug abuse

Table 4-3

Major achievements of drug abuse assay technologies and database establishment